Impact Factor
3.84
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.41
1,295 total citations
h5-index
41
h5 depth signal
Cited share
79.8%
245 of 307
Total citations
1,295
Citation footprint
Metric signal
3.60
External metric anchor
Self-citation
1.4%
18 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
754
China
464
United States
322
Brazil
256
Saudi Arabia
100
Citing Fields of Research
Phytochemicals
346
Protein Structure & Folding
275
Synthesis
233
Cancer Drugs
208
Oncology
196
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,088
Articles tracked across the journal lifetime
Indexed publication set
307
245 cited publications
Last 12 months
301
25.1 publications/month
Open access share
4.0%
12 OA publications in the last year
Leading citing country
India
754 citing publications
Leading citing field
Phytochemicals
346 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v1n1, May 2001-
v1n1, May 2001-
Active Coverage
Research Focus & Classification
Indexed Subjects
Phytochemicals
Neurodegenerative Disorders
Synthesis
Drug Delivery Systems
Cancer Drugs
Protein Structure & Folding
Broad Categories
Chemistry
Phytochemicals
Synthesis
Protein Structure & Folding
Cancer Drugs
Neurodegenerative Disorders
Cancer, Autophagy & Apoptosis
MeSH Descriptors
Chemistry, Pharmaceutical
Drug Design
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.2174/0115680266474686260903044801
Open DOI
Unveiling the Phytopharmacological Potential of Morus alba: Bioactive Constituents, Therapeutic Potential, and Future Prospects
Morus alba L., a member of the Moraceae family, is widely recognised for its medicinal and nutritional importance. Various extracts from Traditional Chinese, Ayurvedic, and Korean medicine systems are widely used, including tree leaves, ...
02
DOI 10.2174/0115680266517367261009103151
Open DOI
Reliability of Machine Learning Approaches Towards the Identification of Novel PI4KIIIβ Inhibitors
Introduction: The type III Phosphatidylinositol 4-kinase (PI4KIIIβ) serves as a key host factor that mediates the replication of RNA viruses and is involved in essential membrane trafficking events. The development of PI4KIIIβ-specific i...
03
DOI 10.2174/0115680266507814260929070719
Open DOI
Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations
Introduction: Ellagic acid, Formononetin, and Glycitein are bioactive polyphenols possessing anticancer activity via apoptosis, cell cycle inhibition, and oncogenic signaling pathway modulation. In particular, Ellagic acid demonstrated i...
04
DOI 10.2174/0115680266495475260908114649
Open DOI
Beyond Phenylbutyric Acid: Evans Blue and Ibuprofen as Albumin- Binding Motifs for PSMA-Targeted Radioligand Therapy of Prostate Cancer
Introduction: Radioligand Therapy (RLT) targeting Prostate-Specific Membrane Antigen (PSMA) reshapes the therapeutic landscape of metastatic castration-resistant prostate cancer. However, the rapid systemic clearance of small-molecule ra...
05
DOI 10.2174/0115680266459999260910044029
Open DOI
In Silico and In vitro Investigation of the Antibacterial Potential of Substituted Aminonitriles
Introduction: Aminonitriles are important synthetic intermediates widely used in the development of compounds with potential antibacterial activity. Previous studies have demonstrated antimicrobial activity in some representatives of thi...
06
DOI 10.2174/0115680266488712260831171806
Open DOI
Artificial Intelligence for Natural Products Discovery and Development
Natural products (NPs) remain a cornerstone of modern drug discovery, offering stereochemical complexity and diverse bioactivities that precisely modulate therapeutic targets, refined through billions of years of evolution. However, thei...
07
DOI 10.2174/0115680266472132260829141305
Open DOI
A Comprehensive Review of Chalcones in Dual-Targeted Therapeutics for the Treatment of Parkinson’s Disease
Introduction: The design of novel therapeutic entities for neurodegenerative diseases, particularly Parkinson’s disease, remains a major challenge in medicinal chemistry. Current treatment strategies primarily rely on symptomatic managem...
08
DOI 10.2174/0115680266473984260826100439
Open DOI
Proteomic Investigation of the Anti-Atherosclerotic Mechanism of 4′,7-di- O-Methylnaringenin from Zingiberaceae Plants
Introduction: Atherosclerosis (AS) is a chronic inflammatory disease driven by disordered lipid metabolism and is a major cause of cardiovascular disease. 4′,7-Di-Omethylnaringenin (DMNG), a natural flavonoid derived from Zingiberaceae p...
09
DOI 10.2174/0115680266497470260826080219
Open DOI
Internal Stimuli-Responsive Nanocarriers for Dermal and Transdermal Drug Delivery: Mechanisms, Materials, and Translational Challenges
Introduction: There are several problems with cutaneous or transdermal drug delivery, including suboptimal drug penetration, an insufficient amount of time for the drug to remain at the target, and drug instability. In response to intrin...
10
DOI 10.2174/0115680266485871260827072414
Open DOI
Synthesis, Structure-Activity Studies, and Therapeutic Potential of Met-enkephalin Derivatives
One potential drug with analgesic, anticancer, and immune-enhancing properties is the endogenous pentapeptide M-ENK (opioid growth factor, OGF). A significant problem limiting its therapeutic application is its low bioavailability and sh...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v. 1, no. 1 (May 2001)20020429 Notice not published Printed on acid-free paper